Arteriosclerosis Thrombosis and Vascular Biology · 2003 · 14 citations · 18 references
MedicinePharmacologyClinical PharmacologyDrug DiscoveryPharmacodynamicsAnticoagulant TherapyAntithrombotic TherapyEnzyme InhibitionNatural Anticoagulant SystemsThrombosisThrombosis PreventionAnticoagulant PharmacologyDirect Thrombin InhibitorsIn Vivo Efficacy TestingPharmacologic ThromboprophylaxisRabbit ModelsThrombin Generation AssaysThrombin Inhibition
OBJECTIVE: In this study we test the hypothesis that blood/plasma-based prothrombinase assays, rather than inhibition of purified factor Xa (fXa), are predictive of in vivo antithrombotic activity. METHODS AND RESULTS: Six fXa inhibitors with equivalent nanomolar Ki were studied in thrombin generation assays using human plasma/blood and endogenous macromolecular substrate. In all assays, benzamidine inhibitors were more potent (100 to 800 nmol/L) than the aminoisoquinolines (5 to 58 micromol/L) or neutral inhibitors (3 to 10 micromol/L). A similar rank order of compound inhibition was also seen in purified prothrombinase assays as well as in a rabbit model of deep vein thrombosis. CONCLUSIONS: Assays using prothrombinase with protein substrates are better predictors of in vivo efficacy than fXa Ki using amidolytic substrates.
18
Surface-dependent reactions of the vitamin K-dependent enzyme complexes
KG Mann, ME Nesheim, W R Church et al. · Blood · 1990 · 857 citations · Full text
The Thrombogram: Monitoring Thrombin Generation in Platelet Rich Plasma
Peter Giesen, Manoj K. Ramjee, Rob Wagenvoord et al. · Thrombosis and Haemostasis · 2000 · 284 citations · Full text
Medicine, Biochemistry, Hematology +12